BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30061225)

  • 1. Morphological Analysis of Amoeboid-Mesenchymal Transition Plasticity After Low and High LET Radiation on Migrating and Invading Pancreatic Cancer Cells.
    Facoetti A; DI Gioia C; Pasi F; DI Liberto R; Corbella F; Nano R; Ciocca M; Valvo F; Orecchia R
    Anticancer Res; 2018 Aug; 38(8):4585-4591. PubMed ID: 30061225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors released by low and high-LET irradiated fibroblasts modulate migration and invasiveness of pancreatic cancer cells.
    Charalampopoulou A; Barcellini A; Ciocca M; Di Liberto R; Pasi F; Pullia MG; Orlandi E; Facoetti A
    Front Oncol; 2022; 12():1003494. PubMed ID: 36313689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and amoeboid motility.
    Fujita M; Otsuka Y; Yamada S; Iwakawa M; Imai T
    Cancer Sci; 2011 Apr; 102(4):792-8. PubMed ID: 21214671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon-ion radiation enhances migration ability and invasiveness of the pancreatic cancer cell, PANC-1, in vitro.
    Fujita M; Otsuka Y; Imadome K; Endo S; Yamada S; Imai T
    Cancer Sci; 2012 Apr; 103(4):677-83. PubMed ID: 22171596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness.
    Vaškovičová K; Szabadosová E; Čermák V; Gandalovičová A; Kasalová L; Rösel D; Brábek J
    BMC Cancer; 2015 Apr; 15():326. PubMed ID: 25924946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition.
    Zhou YC; Liu JY; Li J; Zhang J; Xu YQ; Zhang HW; Qiu LB; Ding GR; Su XM; Mei-Shi ; Guo GZ
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1530-7. PubMed ID: 22115555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of LOXL2 in the promotion of pancreas cancer metastasis.
    Park JS; Lee JH; Lee YS; Kim JK; Dong SM; Yoon DS
    Oncotarget; 2016 Jul; 7(27):42539-42552. PubMed ID: 27285767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
    Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
    J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of motility in metastasizing cells.
    Yilmaz M; Christofori G
    Mol Cancer Res; 2010 May; 8(5):629-42. PubMed ID: 20460404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress of tumor cell migration strategy and the migration transition mechanism].
    Wang H; Tan Q; Yang BY; Zou X; Yang L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1251-6. PubMed ID: 22295724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
    Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
    Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblasts induce epithelial to mesenchymal transition in breast tumor cells which is prevented by fibroblasts treatment with histamine in high concentration.
    Porretti JC; Mohamad NA; Martín GA; Cricco GP
    Int J Biochem Cell Biol; 2014 Jun; 51():29-38. PubMed ID: 24685678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells.
    Kikuta K; Masamune A; Watanabe T; Ariga H; Itoh H; Hamada S; Satoh K; Egawa S; Unno M; Shimosegawa T
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):380-4. PubMed ID: 21081113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gli1 promotes transforming growth factor-beta1- and epidermal growth factor-induced epithelial to mesenchymal transition in pancreatic cancer cells.
    Liu Q; Sheng W; Dong M; Dong X; Dong Q; Li F
    Surgery; 2015 Jul; 158(1):211-24. PubMed ID: 25979438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
    Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
    J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients.
    Zhang J; Zhang L; Li C; Yang C; Li L; Song S; Wu H; Liu F; Wang L; Gu J
    Cell Oncol (Dordr); 2018 Feb; 41(1):73-84. PubMed ID: 29168159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.
    Zheng L; Zhou Z; He Z
    Int J Clin Exp Pathol; 2015; 8(11):14005-12. PubMed ID: 26823712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-enhanced cell migration/invasion process: a review.
    Moncharmont C; Levy A; Guy JB; Falk AT; Guilbert M; Trone JC; Alphonse G; Gilormini M; Ardail D; Toillon RA; Rodriguez-Lafrasse C; Magné N
    Crit Rev Oncol Hematol; 2014 Nov; 92(2):133-42. PubMed ID: 24908570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.